 |
 |

Depression Subtypes and Response to Phenelzine, Diazepam, and a PlaceboResults of a Nine Hospital Collaborative Study
Allen Raskin, PhD;
Joy G. Schulterbrandt, MS;
Natalie Reatig;
Thomas H. Crook, MA;
David Odle
Arch Gen Psychiatry. 1974;30(1):66-75.
Abstract
A total of 325, newly admitted, depressed patients from nine hospitals were randomly assigned to treatment with either diazepam, phenelzine, or a placebo. The study was conducted double-blind and ran for seven weeks. Median daily dosages were 30 mg of diazepam and 45 mg of phenelzine.
The major study finding was the differential effects of diazepam for patients categorized as anxious and hostile depressions. There was a significant number of anxious-depressive patients who were diazepam responders, ie, their symptoms subsided on this treatment and became worse when this drug was discontinued.
In contrast, diazepam was a poor treatment for the hostile depressions. These patients were restless, anxious, negativistic, suspicious, and irritable when they entered the study. These symptoms persisted on diazepam and improved on either phenelzine or a placebo.
Author Affiliations
Rockville, Md
From the National Institute of Mental Health, Psychopharmacology Research Branch, Rockville, Md (Drs. Raskin and Schulterbrandt and N. Reatig and T. Crook), and George Washington University, Biometrics Laboratory, Kensington, Md (D. Odle).
Footnotes
Accepted for publication Sept 12, 1973.
Reprint requests to Rm 9-101 NIMH, 5600 Fishers Lane, Rockville, Md 20852 (Dr. Raskin).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Depressive Symptoms and Depressive Diagnoses in a Community Population: Use of a New Procedure for Analysis of Psychiatric Classification
Blazer et al.
Arch Gen Psychiatry 1988;45:1078-1084.
ABSTRACT
An Efficacy Study of Isocarboxazid and Placebo in Depression, and Its Relationship to Depressive Nosology
Davidson et al.
Arch Gen Psychiatry 1988;45:120-127.
ABSTRACT
Antidepressants: Their efficacy and place in therapy
Paykel
J Psychopharmacol 1988;2:105-118.
ABSTRACT
Panic Disorder and Major Depression: Increased Risk of Depression, Alcoholism, Panic, and Phobic Disorders in Families of Depressed Probands With Panic Disorder
Leckman et al.
Arch Gen Psychiatry 1983;40:1055-1060.
ABSTRACT
Response to Phenelzine and Amitriptyline in Subtypes of Outpatient Depression
Paykel et al.
Arch Gen Psychiatry 1982;39:1041-1049.
ABSTRACT
Monoamine Oxidase Inhibitors: A Review of Antidepressant Effectiveness
Quitkin et al.
Arch Gen Psychiatry 1979;36:749-760.
ABSTRACT
Benzodiazepines in Depressive Disorders
Schatzberg and Cole
Arch Gen Psychiatry 1978;35:1359-1365.
ABSTRACT
Clinical Pharmacology of Phenelzine
Robinson et al.
Arch Gen Psychiatry 1978;35:629-635.
ABSTRACT
Clinical Implications of Imipramine Plasma Levels for Depressive Illness
Glassman et al.
Arch Gen Psychiatry 1977;34:197-204.
ABSTRACT
A Multiple-Dose, Controlled Study of Phenelzine in Depression-Anxiety States
Ravaris et al.
Arch Gen Psychiatry 1976;33:347-350.
ABSTRACT
|